These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30243948)

  • 1. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials.
    de Windt TS; Niemansburg SL; Vonk LA; van Delden JM; Roes KCB; Dhert WJA; Saris DBF; Bredenoord AL
    Osteoarthritis Cartilage; 2019 Jan; 27(1):34-40. PubMed ID: 30243948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participant selection for preventive Regenerative Medicine trials: ethical challenges of selecting individuals at risk.
    Niemansburg SL; Habets MG; Dhert WJ; van Delden JJ; Bredenoord AL
    J Med Ethics; 2015 Nov; 41(11):914-6. PubMed ID: 26340912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field.
    Niemansburg SL; van Delden JJ; Oner FC; Dhert WJ; Bredenoord AL
    Spine J; 2014 Jun; 14(6):1029-35. PubMed ID: 24184644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell trials for cardiovascular medicine: ethical rationale.
    Niemansburg SL; Teraa M; Hesam H; van Delden JJ; Verhaar MC; Bredenoord AL
    Tissue Eng Part A; 2014 Oct; 20(19-20):2567-74. PubMed ID: 24164351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering the ethics of sham interventions in an era of emerging technologies.
    Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL
    Surgery; 2015 Apr; 157(4):801-10. PubMed ID: 25704427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients.
    Niemansburg SL; van Delden JJ; Dhert WJ; Bredenoord AL
    Regen Med; 2013 Jan; 8(1):65-73. PubMed ID: 23259806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethical issues in cluster randomized trials conducted in low- and middle-income countries: an analysis of two case studies.
    Choko AT; Roshandel G; Conserve DF; Corbett EL; Fielding K; Hemming K; Malekzadeh R; Weijer C
    Trials; 2020 Apr; 21(Suppl 1):314. PubMed ID: 32295604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thinking clearly about the FIRST trial: addressing ethical challenges in cluster randomised trials of policy interventions involving health providers.
    Horn AR; Weijer C; Hey SP; Brehaut J; Fergusson DA; Goldstein CE; Grimshaw J; Taljaard M
    J Med Ethics; 2018 Sep; 44(9):593-598. PubMed ID: 29703860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ethics of cluster-randomized trials requires further evaluation: a refinement of the Ottawa Statement.
    van der Graaf R; Koffijberg H; Grobbee DE; de Hoop E; Moons KG; van Thiel GJ; de Wit GA; van Delden JJ
    J Clin Epidemiol; 2015 Sep; 68(9):1108-14. PubMed ID: 25910909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster-randomized trials: A closer look.
    McRae AD; Taljaard M; Weijer C
    Clin Trials; 2016 Jun; 13(3):294-300. PubMed ID: 26931364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed consent in cluster randomised trials: new and common ethical challenges.
    Lignou S
    J Med Ethics; 2018 Feb; 44(2):114-120. PubMed ID: 28780528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
    Kim SY; Flory J; Relton C
    Clin Trials; 2018 Feb; 15(1):9-16. PubMed ID: 29224380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inadequacy of ethical conduct and reporting of stepped wedge cluster randomized trials: Results from a systematic review.
    Taljaard M; Hemming K; Shah L; Giraudeau B; Grimshaw JM; Weijer C
    Clin Trials; 2017 Aug; 14(4):333-341. PubMed ID: 28393537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical considerations for outcome-adaptive trial designs: a clinical researcher's perspective.
    Saxman SB
    Bioethics; 2015 Feb; 29(2):59-65. PubMed ID: 24547903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Members of research ethics committees accepted a modification of the randomized consent design.
    Schellings R; Kessels AG; Ter Riet G; Kleijnen J; Leffers P; Knottnerus JA; Sturmans F
    J Clin Epidemiol; 2005 Jun; 58(6):589-94. PubMed ID: 15878472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive trials in clinical research: scientific and ethical issues to consider.
    van der Graaf R; Roes KC; van Delden JJ
    JAMA; 2012 Jun; 307(22):2379-80. PubMed ID: 22692169
    [No Abstract]   [Full Text] [Related]  

  • 18. Lay public's understanding of equipoise and randomisation in randomised controlled trials.
    Robinson EJ; Kerr CE; Stevens AJ; Lilford RJ; Braunholtz DA; Edwards SJ; Beck SR; Rowley MG
    Health Technol Assess; 2005 Mar; 9(8):1-192, iii-iv. PubMed ID: 15763039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics and stem cell therapeutics for cardiovascular disease.
    Sugarman J
    Prog Cardiovasc Dis; 2007; 50(1):1-6. PubMed ID: 17631433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials in the new millennium.
    DeMets DL
    Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.